{"artifact":{"id":"wiki-therapeutics-ceftriaxone-als","artifact_type":"wiki_page","entity_ids":"[\"therapeutics-ceftriaxone-als\"]","title":"Ceftriaxone for Amyotrophic Lateral Sclerosis","quality_score":0.5,"created_by":"crosslink-migration","provenance_chain":"[]","content_hash":"ca8f00f12f173c2438bd2abbefc6250af5250d4359e767590ca2b50fbcc441c5","metadata":{"slug":"therapeutics-ceftriaxone-als","kg_node_id":null,"entity_type":"therapeutic","origin_type":"v1_polymorphic_backfill","source_table":"wiki_pages","wiki_page_id":"wp-695dd3671a9d","__merged_from":{"merged_at":"2026-05-13","unprefixed_id":"therapeutics-ceftriaxone-als"},"_schema_version":1},"created_at":"2026-04-02T07:18:57-07:00","updated_at":"2026-04-02T13:40:08-07:00","version_number":5,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-02T13:40:08-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"47592850-abc3-4ecc-b4bf-4ce209a5c50c","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"crosslink-migration"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"experiment-exp-wiki-experiments-ad-amyloid-resilient-phenotype","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-wiki-experiments-sex-differences-alzheimers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-wiki-experiments-ad-combination-therapy-trial","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-764173ae-f63f-452f-b821-29c03501fa7c","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: MTOR mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-778c1bc2-7c6e-4cdd-81af-56c535ead1e3","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: MTOR mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-545ecac0-8b8e-4dc1-b999-1118f810815a","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: MTOR mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"experiment-exp-wiki-experiments-blood-biomarker-vs-tau-pet-monitoring","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: GFAP mentioned 2x in wiki/therapeutics-ceftriaxone-als"},{"target_artifact_id":"analysis-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-SDA-2026-04-13-gap-20260410-172514","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-v2-68d9c9c1","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-SDA-2026-04-02-gap-microglial-subtypes-20260402004119","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-006","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-008","link_type":"mentions","strength":0.4,"evidence":"Wiki page matches analysis keyword 'therapeutics'"},{"target_artifact_id":"analysis-SDA-2026-04-02-gap-crispr-neurodegeneration-20260402","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"experiment-exp-wiki-experiments-er-golgi-secretory-pathway-parkinsons","link_type":"related","strength":0.7,"evidence":"Wiki page for ER related to experiment"},{"target_artifact_id":"hypothesis-h-seaad-56fa6428","link_type":"mentions","strength":0.5,"evidence":"KG transitive via GFAP"},{"target_artifact_id":"wiki-entities-gfap","link_type":"see_also","strength":0.6,"evidence":"KG edge: interacts_with"},{"target_artifact_id":"hypothesis-h-51e7234f","link_type":"related","strength":0.5,"evidence":"Wiki content mentions gene MTOR"},{"target_artifact_id":"hypothesis-h-51e7234f","link_type":"mentions","strength":0.65,"evidence":"Wiki page content mentions hypothesis target gene: MTOR"},{"target_artifact_id":"hypothesis-h-44195347","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-d0a564e8","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-11795af0","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-99b4e2d2","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-a20e0cbb","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-seaad-fa5ea82d","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-c9c79e3e","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-15336069","link_type":"mentions","strength":0.5,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"hypothesis-h-b948c32c","link_type":"mentions","strength":0.7,"evidence":"Wiki content mentions gene APOE"},{"target_artifact_id":"analysis-SDA-2026-04-03-gap-crispr-neurodegeneration-20260402","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-sda-2026-04-01-gap-006","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"},{"target_artifact_id":"analysis-sda-2026-04-01-gap-v2-68d9c9c1","link_type":"mentions","strength":0.6,"evidence":"Gene mention: ALS"}],"incoming_links":[{"source_artifact_id":"analysis-sda-2026-04-01-gap-v2-68d9c9c1","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-13-gap-20260410-172514","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-sda-2026-04-01-gap-006","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"hypothesis-h-51e7234f","link_type":"related","strength":0.5850000000000001,"evidence":"Reverse: Wiki page content mentions hypothesis target gene: MTOR"},{"source_artifact_id":"hypothesis-h-b948c32c","link_type":"related","strength":0.63,"evidence":"Reverse: Wiki content mentions gene APOE"},{"source_artifact_id":"analysis-SDA-2026-04-03-gap-crispr-neurodegeneration-20260402","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-08-gap-pubmed-20260406-062212-b66510d9","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-v2-68d9c9c1","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-02-gap-microglial-subtypes-20260402004119","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-006","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"analysis-SDA-2026-04-02-gap-crispr-neurodegeneration-20260402","link_type":"related","strength":0.54,"evidence":"Reverse: Gene mention: ALS"},{"source_artifact_id":"experiment-exp-wiki-experiments-er-golgi-secretory-pathway-parkinsons","link_type":"related","strength":0.7,"evidence":"Experiment targets ER described in wiki"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-008","link_type":"related","strength":0.5,"evidence":"Reverse link"}],"current_artifact_id":"wiki-therapeutics-ceftriaxone-als","is_canonical":true,"supersede_chain":["wiki-therapeutics-ceftriaxone-als"]}